Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Christopher Jones

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
The Annals of Pharmacotherapy|June 16, 2005
Relative thromboembolic risks associated with COX-2 inhibitorsS Christopher Jones
Drug Safety|September 2, 2011
Fluoroquinolone-associated myasthenia gravis exacerbation: evaluation of postmarketing reports from the US FDA adverse event reporting system and a literature reviewS Christopher Jones, Alfred Sorbello, Robert M Boucher
JAMA Dermatology|September 8, 2021
Postmarketing Cases of Enfortumab Vedotin-Associated Skin Reactions Reported as Stevens-Johnson Syndrome or Toxic Epidermal NecrolysisMichelle Nadeau Nguyen, Melissa Reyes, S Christopher Jones
JAMA Ophthalmology|November 6, 2025
Systemic Toxicity With Use of Apraclonidine Ophthalmic Drops in Pediatric PatientsPaula Gish, Ivone Kim, Rachna Kapoor, et al.
Clinical Toxicology (Philadelphia, Pa.)|September 22, 2020
Harmful effects of chlorine dioxide exposureAllison Lardieri, Carmen Cheng, S Christopher Jones, et al.
Drug Safety|April 6, 2020
Systemic Adverse Events Associated with Compounded Topical Pain ProductsJenny Kim, Karen Konkel, S Christopher Jones, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|May 15, 2021
Abiraterone acetate-associated QT prolongation and torsades de pointes: Postmarketing cases reported to FDALauren McBride, Daniel Woronow, Afrouz Nayernama, et al.
Pharmacoepidemiology and Drug Safety|August 22, 2013
US-based emergency department visits for fluoroquinolone-associated hypersensitivity reactionsS Christopher Jones, Daniel S Budnitz, Alfred Sorbello, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 14, 2012
Reply to Ison et AlAlfred Sorbello, S Christopher Jones, Debra Birnkrant, et al.
The Journal of Allergy and Clinical Immunology. Global|November 11, 2025
Drug-induced enterocolitis syndrome with amoxicillin-containing products: A review of cases reported to the FDA adverse event reporting system and published literatureMaya Beganovic, Rachna Kapoor, S Christopher Jones, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
The Annals of Pharmacotherapy|June 16, 2005
Relative thromboembolic risks associated with COX-2 inhibitorsS Christopher Jones
Drug Safety|September 2, 2011
Fluoroquinolone-associated myasthenia gravis exacerbation: evaluation of postmarketing reports from the US FDA adverse event reporting system and a literature reviewS Christopher Jones, Alfred Sorbello, Robert M Boucher
JAMA Dermatology|September 8, 2021
Postmarketing Cases of Enfortumab Vedotin-Associated Skin Reactions Reported as Stevens-Johnson Syndrome or Toxic Epidermal NecrolysisMichelle Nadeau Nguyen, Melissa Reyes, S Christopher Jones
JAMA Ophthalmology|November 6, 2025
Systemic Toxicity With Use of Apraclonidine Ophthalmic Drops in Pediatric PatientsPaula Gish, Ivone Kim, Rachna Kapoor, et al.
Clinical Toxicology (Philadelphia, Pa.)|September 22, 2020
Harmful effects of chlorine dioxide exposureAllison Lardieri, Carmen Cheng, S Christopher Jones, et al.
Drug Safety|April 6, 2020
Systemic Adverse Events Associated with Compounded Topical Pain ProductsJenny Kim, Karen Konkel, S Christopher Jones, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|May 15, 2021
Abiraterone acetate-associated QT prolongation and torsades de pointes: Postmarketing cases reported to FDALauren McBride, Daniel Woronow, Afrouz Nayernama, et al.
Pharmacoepidemiology and Drug Safety|August 22, 2013
US-based emergency department visits for fluoroquinolone-associated hypersensitivity reactionsS Christopher Jones, Daniel S Budnitz, Alfred Sorbello, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 14, 2012
Reply to Ison et AlAlfred Sorbello, S Christopher Jones, Debra Birnkrant, et al.
The Journal of Allergy and Clinical Immunology. Global|November 11, 2025
Drug-induced enterocolitis syndrome with amoxicillin-containing products: A review of cases reported to the FDA adverse event reporting system and published literatureMaya Beganovic, Rachna Kapoor, S Christopher Jones, et al.
Pageof 4